Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.
Upper limb functional electrical stimulation devices and their man-machine interfaces.
Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions.
Effects of magnetization transfer on T1 contrast in human brain white matter.
Change of Th17 Lymphocytes and Treg/Th17 in Typical and Atypical Optic Neuritis.
MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up.
Modulating effects of WT1 on interferon-β-vitamin D association in MS.
Jugular Venous Flow Abnormalities in Multiple Sclerosis Patients Compared to Normal Controls.
Effect of Tai Chi Chuan on balance in women with multiple sclerosis.
Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis.
Expanded CD8 T-cell sharing between periphery and CNS in multiple sclerosis.
Contribution of Functional LILRA3, but Not Nonfunctional LILRA3, to Sex Bias in Susceptibility and Severity of Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis.
KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis.
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes.
CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.
Moving to fingolimod from natalizumab in multiple sclerosis-reply.
Symptomatic Sinus Bradycardia After a Treatment Course Of High-dose Oral Prednisone.
T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: Role of IL-2.
Correction: Acute Disseminated Encephalomyelitis Onset: Evaluation Based on Vaccine Adverse Events Reporting Systems.
Involvement of Toso in activation of monocytes, macrophages, and granulocytes.
[Treatment of transplantation of NT-3 gene modified olfactory ensheathing cells on experimental autoimmune encephalomyelitis in rats].
Ginger Extract Reduces the Expression of IL-17 and IL-23 in the Sera and Central Nervous System of EAE Mice.
Characterization of anti-natalizumab antibodies in multiple sclerosis patients.
The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
Pages
« first
‹ previous
…
388
389
390
391
392
393
394
395
396
…
next ›
last »